Send a Tweet
Most Popular Choices
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Tell A Friend Printer Friendly Page Save As Favorite View Favorites
General News

'Pharma bro' Martin Shkreli gets 7 years in prison

Quicklink Submitted By   Follow Me on Twitter     Message Meryl Ann Butler     Permalink    (# of views)   2 comments

Related Topic(s): ; ; , Add Tags

Must Read 2   Valuable 2   Well Said 1  
View Ratings | Rate It

opednews.com Headlined to H3 3/10/18

Become a Fan
  (86 fans)

From commons.wikimedia.org: Martin Shkreli House Committee on Oversight and Government Reform 2016 {MID-65109}
Martin Shkreli House Committee on Oversight and Government Reform 2016
(Image by Wikipedia (commons.wikimedia.org))
  Permission   Details   DMCA

Convicted fraudster Martin Shkreli is sentenced for securities fraud related to two hedge funds he ran and to his former drug company Retrophin. The notorious 'pharma bro' gained infamy for raising the price of the drug Daraprim by more than 5000 percent while running the company then known as Turing Pharmaceuticals. Shkreli already has been ordered to forfeit almost $7.4 million.

Read the rest of the story HERE:

At www.cnbc.com

 

- Advertisement -

Must Read 2   Valuable 2   Well Said 1  
View Ratings | Rate It

opednews.com

Meryl Ann Butler is an artist, author, educator and OpedNews Managing Editor who has been actively engaged in utilizing the arts as stepping-stones toward joy-filled wellbeing since she was a hippie. She began writing for OpEdNews in Feb, 2004. She became a Senior Editor in August 2012 and Managing Editor in January, (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon Share Author on Social Media   Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Follow Me on Twitter

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles